Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1

Journal of Nuclear Medicine

Volumn 40, Issue 12, 1999, Pages 2073-2080

  Welling, Mick M ^b   Nibbering, Peter H ^b   Paulusma Annema, Akke ^b   Hiemstra, Pieter S ^b   Pauwels, Ernest K J ^a   Calame, Wim ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

99mTc labeling; Bacteria; Human neutrophil peptide 1; Infection imaging

Indexed keywords

TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ALPHA-DEFENSINS; ANIMALS; DEFENSINS; HINDLIMB; IMMUNOGLOBULIN G; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LEUKOCYTES; MALE; MICE; MUSCULAR DISEASES; PERITONEAL DISEASES; PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TECHNETIUM;

EID: 0033381722     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Becker W. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med. 1995;22:1195-1211.
2. Peters AM. The use of nuclear medicine in infections. Br J Radiol. 1998;71:252-261.
3. 99mTechnetium-Labelled Tracers: An Optimization Study [dissertation]. Leiden, The Netherlands: University of Leiden; 1997.
4. 99mTc-Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233-235.
5. Bäumler AJ, Heffron F. Microbial resistance to macrophage effector functions: strategies for evading microhicidal mechanisms and scavenging nutrients within mononuclear phagocytes. In: Brogden KA, Minion FC, Wannemuehler MJ, Roth JA, Bolin CA, eds. Virulence Mechanisms of Bacterial Pathogens. 2nd ed. Washington, DC: American Society for Microbiology; 1995:115-131.
6. Rubin RH, Young LS, Hansen WP, et al. Specific and nonspecific imaging of localized Fisher immunotype I Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nuc/ Med. 1988;29:651-656.
7. Hancock REW. Peptide antibiotics. Lancet. 1997;349:418-422.
8. Welling MM, Hiemstra PS, van den Barselaar MT, et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest. 1998;102:1583-1590.
9. Nibbering PH, Welling MM, van den Broek PJ, van Wyngaarden KE, Pauwels EKJ, Calame W. Radiolabelled antimicrobial peptides for imaging of infections. Nucl Med Commun. 1998;19:1117-1121.
10. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol. 1994;6:584-589.
11. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol. 1993;11:105-128.
12. Ganz T, Selsted ME, Szklarek D, et al. Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76:1427-1435.
13. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity. J Clin Invest. 1989;84:553-561.
14. Daher KA, Selsled ME, Lehrer RI. Direct inactivation of viruses by human granulocy te defensins. J Virol. 1986;60:1068-1074.
15. van Wetering S, Mannesse-Lazeroms SPG, van Sterkenburg MAJA, Daha MR, Dijkman JH, Hiemstra PS. Effects of defensins on IL-8 synthesis in airway epithelial cells. Am J Physiol. 1997;272:888-896.
16. 4 and stannous chloride. Nucl Med Biol. 1993;20:825-833.
17. Kunst MW, Mattie H. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. J Inject Dis. 1978;137:391-402.
18. 99mTc-labeled polyclonal human immunoglobulin. J Nucl Med. 1991;32:468-474.
19. Hiemstra PS, van den Barselaar MT, Roest M, Nibbering PH, van Furth R. Ubiquicidin, a novel murine microbicidal protein in the cytosolic fraction of activated macrophages. J Leukoc Biol. 1999;66:423-428.
20. Calame W, Welling MM, Feitsma RIJ, Goedemans WT, Pauwels EKJ. Contribution of phagocytic cells and bacteria to the accumulation of technetium-99m labelled polyclonal human immunoglobulin at sites of inflammation. Eur J Nucl Med. 1995;22:638-644.
21. 99mTc-labeled monoclonal antibodies against TNF-alpha and interleukin-8. Nucl Med Biol. 1997;24:649-655.
22. Panyutich A, Ganz T. Activaled alpha 2-macroglobulin is a principal defensin-binding protein. Am J Respir Cell Mol Biol. 1991;5:101-106.
23. Ihi T, Nakazato M, Mukae H, Matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997;25:1134-1140.
24. Soong LB, Ganz T, Ellison A, Caughey GH. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res. 1997;46:98-102.
25. Bevins CL. Antimicrobial peptides as agents of mucosal immunity. Ciba Found Symp. 1994;186:250-269.